Metabolic syndrome in a sample of the 6- to 16-year-old overweight or obese pediatric population: A comparison of two definitions

Therapeutics and Clinical Risk Management

Volumn 8, Issue , 2012, Pages 55-63

  Saffari, Fatemeh ^a   Jalilolghadr, Shabnam ^a   Esmailzadehha, Neda ^a   Azinfar, Peyman ^a  

^a QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adolescents; Body mass index; Children; Metabolic syndrome; Obesity

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL EXAMINATION; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 84857090366     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/TCRM.S26673     Document Type: Article

References (59)

1. De Onis M, Blössner M. Prevalence and trends of overweight among preschool children in developing countries. Am J Clin Nutr. 2000; 72(4):1032-1039.
2. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288(14):1728-1732.
3. Lobstein T, Baur L, Uauy R; IASO International Obesity Task Force. Obesity in children and young people: a crisis in public health. Obes Rev. 2004;5(Suppl 1):4-104.
4. Perichart-Perera O, Balas-Nakash M, Schiffman-Selechnik E, Barbato-Dosal A, Vadillo-Ortega F. Obesity increases metabolic syndrome risk factors in school-aged children from an urban school in Mexico City. J Am Diet Assoc. 2007;107(1):81-91.
5. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103(6 Pt 1):1175-1182.
6. Hanefeld M, Leonhardt W. The metabolic syndrome [Das metabolische syndrom]. Dtsch Gesundheitsw. 1981;36:545-551. [German.]
7. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.
8. Levitt NS, Lambert EV. The foetal origins of the metabolic syndrome: a South African perspective. Cardiovasc J S Afr. 2002;13(4):179-180.
9. Ozanne SE, Hales CN. Early programming of glucose-insulin metabolism. Trends Endocrinol Metab. 2002;13(9):368-373.
10. Onat A, Ceyhan K, Başar O, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels: a prospective and cross-sectional evaluation. Atherosclerosis. 2002;165(2):285-292.
11. Kelishadi R, Gouya MM, Adeli K, et al. Factors associated with the metabolic syndrome in a national sample of youths: CASPIAN Study. Nutr Metab Cardiovasc Dis. 2008;18(7):461-470. Epub November 1, 2007.
12. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362-2374.
13. López-Capapé M, Alonso M, Colino E, Mustieles C, Corbatón J, Barrio R. Frequency of the metabolic syndrome in obese Spanish pediatric population. Eur J Endocrinol. 2006;155(2):313-319.
14. Lambert M, Paradis G, O'Loughlin J, Delvin EE, Hanley JA, Levy E. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004;28(7):833-841.
15. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr. 2004;145(4):445-451.
16. De Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110(16):2494-2497. Epub October 11, 2004.
17. Love-Osborne KA, Nadeau KJ, Sheeder J, Fenton LZ, Zeitler P. Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease. J Adolesc Health. 2008;42(6):543-548. Epub March 4, 2008.
18. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-1428.
19. Lustig RH, Weiss R. Disorders of energy balance In: Sperling MA, editor. Pediatric Endocrinology. 3rd ed. Philadelphia: Saunders Elsevier; 2008:788-838.
20. Kong AS, Williams RL, Smith M, et al. Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices. Ann Fam Med. 2007;5(3):202-208.
21. World Health Organization. Physical status: the use and interpretation of anthropometry; report of a WHO expert committee. World Health Organ Tech Rep Ser. 1995;854:1-452.
22. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555-576.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
24. Esteghamati A, Ashraf H, Khalilzadeh O, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond). 2010;7:26.
25. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
26. Altman DG. Practical Statistics for Medical Research. 1st ed. London: Chapman and Hall; 1991.
27. Calcaterra V, Klersy C, Muratori T, et al. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol (Oxf). 2008;68(6):868-872. Epub November 2, 2007.
28. Pedrosa C, Oliveira BM, Albuquerque I, Simões-Pereira C, Vaz-de-Almeida MD, Correia F. Obesity and metabolic syndrome in 7-9 years-old Portuguese schoolchildren. Diabetol Metab Syndr. 2010;2(1):40.
29. Lafortuna CL, Adorni F, Agosti F, et al. Prevalence of the metabolic syndrome among extremely obese adolescents in Italy and Germany. Diabetes Res Clin Pract. 2010;88(1):14-21. Epub January 21, 2010.
30. Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child. 2005;90(1):10-14.
31. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004;89(1):108-113.
32. Atabek ME, Pirgon O, Kurtoglu S. Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diabetes Res Clin Pract. 2006;72(3):315-321. Epub December 1, 2005.
33. Csábi G, Török K, Jeges S, Molnár D. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr. 2000;159(1-2): 91-94.
34. Druet C, Dabbas M, Baltakse V, et al. Insulin resistance and the metabolic syndrome in obese French children. Clin Endocrinol (Oxf). 2006;64(6):672-678.
35. Ferreira AP, Oliveira CE, França NM. Metabolic syndrome and risk factors for cardiovascular disease in obese children: the relationship with insulin resistance (HOMA-IR). J Pediatr (Rio J). 2007;83(1):21-26. Epub November 28, 2006.
36. Sartorio A, Agosti F, De Col A, Mornati D, Francescato MP, Lazzer S. Prevalence of the metabolic syndrome in Caucasian obese children and adolescents: comparison between three different definition criteria. Diabetes Res Clin Pract. 2007;77(2):341-342. Epub January 22, 2007.
37. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157(8):821-827.
38. Ravaglia G, Forti P, Maioli F, et al. Metabolic syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care. 2006;29(11):2471-2476.
39. Magi L, Stramenga C, Morosini P; Gruppo di Studio SIMAP. Prevalence of the metabolic syndrome among Italian adults: findings from the SIMAP study. Recenti Prog Med. 2005;96(6):280-283. Italian.
40. Saland JM. Update on the metabolic syndrome in children. Curr Opin Pediatr. 2007;19(2):183-191.
41. Bokor S, Frelut ML, Vania A, et al. Prevalence of metabolic syndrome in European obese children. Int J Pediatr Obes. 2008;3(Suppl 2):3-8.
42. DuBose KD, Stewart EE, Charbonneau SR, Mayo MS, Donnelly JE. Prevalence of the metabolic syndrome in elementary school children. Acta Paediatr. 2006;95(8):1005-1011.
43. Stoddart ML, Blevins KS, Lee ET, Wang W, Blackett PR; Cherokee Diabetes Study. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study. Diabetes Care. 2002;25(6):1009-1014.
44. Mukhtar Q, Cleverley G, Voorhees RE, McGrath JW. Prevalence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents. J Adolesc Health. 2001;28(5):372-376.
45. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005;28(4):902-909.
46. Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep. 2004;4(1):53-62.
47. Reinehr T, de Sousa G, Andler W. Longitudinal analyses among overweight, insulin resistance, and cardiovascular risk factors in children. Obes Res. 2005;13(10):1824-1833.
48. Voss LD, Metcalf BS, Jeffery AN, Wilkin TJ. IOTF thresholds for overweight and obesity and their relation to metabolic risk in children (EarlyBird 20). Int J Obes (Lond). 2006;30(4):606-609.
49. Nathan BM, Moran A. Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes. 2008;15(1):21-29.
50. Reinehr T, de Sousa G, Wabitsch M. Changes of cardiovascular risk factors in obese children effects of inpatient and outpatient interventions. J Pediatr Gastroenterol Nutr. 2006;43(4):506-511.
51. Reinehr T, Kleber M, Toschke AM. Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis. 2009;207(1):174-180. Epub April 5, 2009.
52. Reinehr T, de Sousa G, Toschke AM, Andler W. Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child. 2007;92(12):1067-1072. Epub February 14, 2007.
53. Invitti C, Maffeis C, Gilardini L, et al. Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes (Lond). 2006;30(4):627-633.
54. Noto D, Niglio T, Cefalù AB, et al. Obesity and the metabolic syndrome in a student cohort from southern Italy. Nutr Metab Cardiovasc Dis. 2009;19(9):620-625. Epub March 3, 2009.
55. Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation. 2004;110(7):803-809. Epub August 2, 2004.
56. Porkka KV, Viikari JS, Rönnemaa T, Marniemi J, Akerblom HK. Age and gender specific serum lipid and apolipoprotein fractiles of Finnish children and young adults: the Cardiovascular Risk in Young Finns study. Acta Paediatr. 1994;83(8):838-848.
57. Hickman TB, Briefel RR, Carroll MD, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med. 1998;27(6):879-890.
58. Brotons Cuixart C, Gabriel Sánchez R, Muñiz García J, et al. Pattern of the distribution of total cholesterol and cHDL cholesterol Spanish children and adolescents: RICARDIN Study. Med Clin (Barc). 2000;115(17):644-649. Spanish.
59. Menghetti E, Virdis R, Strambi M, et al. Blood pressure in childhood and adolescence: the Italian normal standards. J Hypertens. 1999; 17(10):1363-1372.